查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
医疗设备偿付市场:付款者，医疗保健环境，各地区-规模，占有率，展望，机会分析，2023年～2030年
市场调查报告书
商品编码
1290636

医疗设备偿付市场:付款者，医疗保健环境，各地区-规模，占有率，展望，机会分析，2023年～2030年

Medical Devices Reimbursement Market, By Payers, By Healthcare Setting, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场动态:

慢性疾病的盛行率的增加，老年人口的增加，医疗费的增加，政府的辅助策略/计划，全球医疗设备偿付增大是预计促进全球医疗器械报销市场增长的关键因素。

本调查的主要特征

  • 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球医疗设备偿付市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
  • 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球医疗设备偿付市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球医疗设备偿付市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球医疗设备偿付市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查的目的与前提条件

  • 调查的目的
  • 前提条件
  • 简称

第2章 市场展望

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • 连贯·机遇·地图(COM)

第3章 市场动态，法规，趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 影响分析
  • 主要的焦点
  • 法规方案
  • 产品销售/核准
  • PEST分析
  • PORTER的分析
  • 合併·收购情势

第4章 医疗设备偿付市场-冠状病毒(COVID-19)大流行病的影响

  • 关于COVID-19流行病学
  • 供给面和需求面的分析
  • 经济影响

第5章 医疗设备偿付的全球市场，付款者，2017-2030年

  • 公共
  • 民间

第6章 医疗设备偿付市场世界，医疗保健环境，2017年～2030年

  • 医院
  • 门诊病人设施
  • 其他

第7章:医疗设备偿付的全球市场，各地区，2017年～2030年

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲地区

第8章 竞争情形

  • BNP Paribas
  • CVS Health
  • Aviva
  • Allianz
  • Humana
  • Cigna
  • Aetna
  • Wellcare Health Plans Inc.
  • UnitedHealth Group Inc.
  • Nippon Life Insurance Company

第9章 章节

  • 关于调查手法
  • 关于出版社
简介目录
Product Code: CMI5755

Medical devices reimbursement is a payment private insurer pays to healthcare providers for costs the provider incurred while using medical devices. Usually, health insurer or government payers cover the patients' healthcare expenses inclusive of medical device use. It is important because it ensures that patients have access to the medical devices they need.

Market Dynamics:

Increasing prevalence of chronic diseases, growing geriatric (aging) population, increasing cost of healthcare, and supportive government initiatives/programs are major factors expected to augment the growth of the global medical devices reimbursement market.

For instance, in November 2022, RQM+ announced the launch of its reimbursement division. RQM+ reimbursement services range from initial reimbursement strategy development to post-approval market access support. RQM+ now provides comprehensive reimbursement services in addition to regulatory, quality, clinical, and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics.

Key features of the study:

  • This report provides in-depth analysis of the global medical devices reimbursement market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global medical devices reimbursement market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include BNP Paribas, CVS Health, Aviva, Allianz, Humana, Cigna, Aetna, Wellcare Health Plans Inc., UnitedHealth Group Inc., and Nippon Life Insurance Company, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global medical devices reimbursement market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical devices reimbursement market.

Detailed Segmentation:

  • Global Medical Devices Reimbursement Market, By Payers:
    • Public
    • Private
  • Global Medical Devices Reimbursement Market, By Healthcare Setting:
    • Hospitals
    • Outpatient Facilities
    • Others
  • Global Medical Devices Reimbursement Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • BNP Paribas
    • CVS Health
    • Aviva
    • Allianz
    • Humana
    • Cigna
    • Aetna
    • Wellcare Health Plans Inc.
    • UnitedHealth Group Inc.,
    • Nippon Life Insurance Company

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Payers
    • Market Snapshot, By Healthcare Setting
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • High prevalence of chronic diseases and growing geriatric population
    • Complex framework and limited coverage and reimbursement
    • Increasing cost of healthcare and supportive government initiatives
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Medical Devices Reimbursement Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Medical Devices Reimbursement Market, By Payers, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Medical Devices Reimbursement Market, By Healthcare Setting, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Outpatient Facilities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Medical Devices Reimbursement Market, By Region, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)

8. Competitive Landscape

  • BNP Paribas
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CVS Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aviva
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Allianz
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Humana
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cigna
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aetna
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Wellcare Health Plans Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • UnitedHealth Group Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nippon Life Insurance Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us